739 related articles for article (PubMed ID: 17942684)
1. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
[TBL] [Abstract][Full Text] [Related]
2. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes.
Wenzlau JM; Moua O; Sarkar SA; Yu L; Rewers M; Eisenbarth GS; Davidson HW; Hutton JC
Ann N Y Acad Sci; 2008 Dec; 1150():256-9. PubMed ID: 19120307
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
5. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
[TBL] [Abstract][Full Text] [Related]
6. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
[TBL] [Abstract][Full Text] [Related]
8. Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India.
Shivaprasad C; Mittal R; Dharmalingam M; Kumar PK
Indian J Endocrinol Metab; 2014 May; 18(3):345-9. PubMed ID: 24944929
[TBL] [Abstract][Full Text] [Related]
9. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
10. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
[TBL] [Abstract][Full Text] [Related]
11. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
12. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
[TBL] [Abstract][Full Text] [Related]
13. Zinc transporter 8 autoantibodies assessment in daily practice.
Hussein H; Ibrahim F; Sobngwi E; Gautier JF; Boudou P
Clin Biochem; 2017 Jan; 50(1-2):94-96. PubMed ID: 27363941
[TBL] [Abstract][Full Text] [Related]
14. Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
Gu Y; Merriman C; Guo Z; Jia X; Wenzlau J; Li H; Li H; Rewers M; Yu L; Fu D
J Autoimmun; 2021 Aug; 122():102677. PubMed ID: 34130115
[TBL] [Abstract][Full Text] [Related]
15. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
[TBL] [Abstract][Full Text] [Related]
17. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
[TBL] [Abstract][Full Text] [Related]
19. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
Andersson C; Larsson K; Vaziri-Sani F; Lynch K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Månsson M; Nilsson A; Lernmark A; Elding Larsson H; Ivarsson SA
Autoimmunity; 2011 Aug; 44(5):394-405. PubMed ID: 21244337
[TBL] [Abstract][Full Text] [Related]
20. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]